St. Louis Children's Hospital, Washington University MO
September 12-14, 2024
Click on the exhibitor/sponsor logo to view more information on the organization's website.
The mission of the Adult Congenital Heart Association (ACHA) is to empower the congenital heart disease community by advancing access to resources and specialized care that improve patient-centered outcomes. Founded in 1998, ACHA is an organization begun by and dedicated to supporting individuals and families living with congenital heart disease and advancing the care and treatment available to our community. We do this through a wide and growing range of programs, services and activities. These include our National and Regional Conferences, accreditation program, educational materials, website, outreach and advocacy efforts, research program, and events to raise money and increase awareness. We are committed to promoting excellence for every adult CHD patient by increasing access to the highest level of care and developing standards to allow patients and families to identify physicians and facilities providing that care. Our vision is that every adult with CHD receives specialized cardiac care. ACHA thanks the patients, family members, health professionals and researchers who commit their time, resources, skills and efforts to our cause. We especially acknowledge the contributions of our Board of Directors and Medical Advisory Board. Read more in ACHA's one page overview, click here. To learn more about Karen Klein McNulty, ACHA's co-founder and first president, click here. ACHA is proud to be a Four-Star Charity on Charity Navigator, with a score of 100%. Click here to learn more. In addition, we have earned the Platinum Seal of Transparency from Candid. Click here to review our profile. |
The Eleanor Grace Memorial Foundation is dedicated to providing housing and support for pregnant women and families from out of town who have infants suffering from congenital heart disease (CHD) at St. Louis Children’s Hospital. Our mission is to eliminate the burden, expense and logistics of travel by providing a safe, comfortable and affordable home-away-from-home near the hospital, the Heart House. Our foundation is based on the belief that financial instability or lack of housing should not preclude parents from experiencing precious time with their babies. The Heart House enables families to focus on bonding with their babies, celebrate precious moments, and make the most of their time with their baby, especially in cases where the child may not survive. When the child is expected to survive, we believe that strong family support has a transformative effect on the well-being and development of babies with CHD. For those families, the Heart House enables parents to actively participate in their babies’ care and provide love and support, ultimately giving their babies the best chance at a healthy future. |
The mission of the Mighty Oakes Heart Foundation is to support families of children diagnosed with congenital heart defects financially, emotionally, and in ways unique to their needs. We provide financial grants to heart families to help parents spend less time worrying about bills and other basic daily stresses, to help them concentrate more on the emotional support they give to their child fighting a congenital heart defect. |
Prolacta Bioscience, Inc. is a privately held life sciences company dedicated to Advancing the Science of Human Milk®. The company pioneered the development of human milk-based nutritional products to meet the needs of critically ill, premature infants in the NICU and leads the industry in the quality and safety of nutritional products made from breast milk. Prolacta operates the first and only pharmaceutical-grade manufacturing facility for the processing of human breast milk. For more information please visit www.prolacta.com |